Neuroradiological Viewpoint on the Diagnostics of Space-Occupying Brain Lesions
Authors:
- 3 May 2011
- journal article
- review article
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 21 (3) , 123-139
Abstract
Conventional magnetic resonance (MR) imaging of space-occupying lesions may answer most of the questions concerning the diagnosis and subsequent treatment strategies if patient age, clinical and paraclinical findings are considered as well. However, crucial and relevant differential diagnoses require additional MR methods, such as diffusion-weighted imaging (DWI), perfusion-weighted imaging (PWI) and magnetic resonance spectroscopy (MRS). In necrotic ring-enhancing lesions DWI may detect inflammatory processes, whereas characteristics of the peritumoral area may help to distinguish between metastases and glioblastomas. In solid tumors DWI, PWI and MRS may also aid the differentiation between low-grade gliomas and malignant tumors, such as gliomas WHO (World Health Organization) grade III and IV and lymphomas. This review briefly explains special MR methods with respect to brain tumors and illustrates the diagnostic pathways necessary for supplying a reliable diagnosis as well as optimal pre-operative imaging of space-occupying brain lesions. Unter Berücksichtigung von Patientenalter, neurologischen Symptomen und paraklinischer Information kann man mithilfe der konventionellen Magnetresonanztomographie einen Großteil der Fragen hinsichtlich der Diagnose zerebraler Raumforderungen sowie anschließender Therapieoptionen beantworten. Wichtige Differentialdiagnosen bedürfen jedoch zusätzlicher MR Methoden wie Diffusionswichtung (DWI), MR Perfusion (PWI) und MR Spektroskopie (MRS). So kann z. B. die DWI in nekrotischen und randständig anreichernden Läsionen einen entzündlichen Prozess aufdecken, während spezielle Eigenschaften der peritumoralen Region bei der Differenzierung von Metastasen und Glioblastomen helfen. In soliden Tumoren können DWI, PWI und MRS die Unterscheidung zwischen niedriggradigen und malignen Tumoren entsprechend WHO (World Health Organization) Grad III und IV Gliomen und Lymphomen erleichtern. In dieser Übersicht werden spezielle MR Methoden in Bezug auf Hirntumore kurz dargestellt sowie diagnostische Schritte illustriert, die nötig sind, um eine verlässliche Diagnose zu stellen und eine optimale präoperative Bildgebung zu gewährleisten.Keywords
This publication has 68 references indexed in Scilit:
- Prognostic significance of contrast-enhancing anaplastic astrocytomas in adultsJournal of Neurosurgery, 2010
- Magnetic Resonance Imaging Features of Pilocytic Astrocytoma of the Brain Mimicking High-Grade GliomasJournal of Computer Assisted Tomography, 2010
- DIAGNOSTIC VALUE OF PROTON MAGNETIC RESONANCE SPECTROSCOPY IN THE NONINVASIVE GRADING OF SOLID GLIOMASNeurosurgery, 2009
- Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR ImagingRadiology, 2008
- MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literatureNeuroradiology, 2007
- MR-Perfusions- und spektroskopische Bildgebung bei WHO-Grad-II-AstrozytomenDer Radiologe, 2006
- Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-l-tyrosine and magnetic resonance spectroscopyJournal of Neurosurgery, 2005
- Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesionsNeuroradiology, 2002
- Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Gliomas: classification with MR imaging.Radiology, 1990